Fig. 3.
Fig. 3. Dose- and time-dependent inhibition of inflammatory cytokines by ritonavir. / Human PBMCs were stimulated with anti-CD3 mAbs and treated with the indicated concentrations of ritonavir (30 μmol/L [♦], 10 μmol/L [▴], 3 μmol/L [▪], and untreated control [○]). Supernatants were collected at indicated time points, cleared, and assayed for cytokines by ELISA, (A) IFN-γ, (B) TNF-α, (C) IL-1β, and (D) IL-6. Results from one representative experiment are shown of 4 performed with similar data. Data points illustrated represent means of duplicate determinations, SD ≤ 12%.

Dose- and time-dependent inhibition of inflammatory cytokines by ritonavir.

Human PBMCs were stimulated with anti-CD3 mAbs and treated with the indicated concentrations of ritonavir (30 μmol/L [♦], 10 μmol/L [▴], 3 μmol/L [▪], and untreated control [○]). Supernatants were collected at indicated time points, cleared, and assayed for cytokines by ELISA, (A) IFN-γ, (B) TNF-α, (C) IL-1β, and (D) IL-6. Results from one representative experiment are shown of 4 performed with similar data. Data points illustrated represent means of duplicate determinations, SD ≤ 12%.

Close Modal

or Create an Account

Close Modal
Close Modal